Michael Brophy, an officer of Natera, Inc., filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 470 shares of Natera common stock with an aggregate market value of $178,092.40.
Key Highlights
- Proposed sale: 470 shares of Natera common stock, with an aggregate market value of $178,092.40, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Acquisition source: The 470 shares were acquired on October 31, 2026, via restricted stock units granted by Natera, Inc. as the issuer.
- Approximate sale date: November 3, 2026, on the NASDAQ exchange.
- Shares outstanding: According to the filing, Natera had 144,144,170 shares of common stock outstanding.
- Prior sales disclosed: The filing lists several sales of Natera common stock by Brophy during the past three months, including 325 shares on November 2, 2026, generating gross proceeds of $129,997.50, and 1,906 shares on October 30, 2026, generating gross proceeds of $811,098.30.
- Trading plan: The filing references a Rule 10b5-1 trading plan adopted on September 10, 2025.
Brophy's Proposed Common Stock Sale and Recent Transaction History at Natera
According to the Form 144 filing, Michael Brophy, identified as an officer of Natera, Inc. (NASDAQ:NTRA), is proposing to sell 470 shares of the company's common stock. Natera is a genetic testing and diagnostics company headquartered at 13011 McCallen Pass, Bldg A Suite 100, Austin, Texas. The shares proposed for sale were acquired on October 31, 2026, through restricted stock units issued by the company, with payment listed as not applicable in the filing.
The filing also discloses Brophy's prior sales of Natera common stock during the three months preceding the notice date. Those transactions include: 325 shares sold on November 2, 2026, with gross proceeds of $129,997.50; 1,906 shares sold on October 30, 2026, with gross proceeds of $811,098.30 under a 10b5-1 plan; 1,198 shares sold on October 28, 2026, with gross proceeds of $510,755.80; 1,178 shares sold on October 28, 2026, with gross proceeds of $502,371.65 under a 10b5-1 plan; 781 shares sold on October 27, 2026, with gross proceeds of $317,086.00; and 478 shares sold on August 4, 2026, with gross proceeds of $131,077.16 under a 10b5-1 plan.
The filing states that the proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. Brophy signed the notice on November 3, 2026, and indicated the Rule 10b5-1 trading plan was adopted on September 10, 2025.
What Was Disclosed
Natera officer Michael Brophy filed a Form 144 on November 3, 2026, notifying the SEC of a proposed sale of 470 shares of Natera common stock valued at $178,092.40, acquired via restricted stock units, along with a history of prior sales during the preceding three months.



Please wait processing your request...